ArticleBMC medical research methodology2025
Omitting patients with no follow-up leads to bias when using inverse-intensity weighted GEEs to handle irregular and informative assessment times.
Article in BMC medical research methodology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLongitudinal data can be used to study disease progression and are often collected at irregular intervals. When the assessment times are informative about the severity of the disease, regression analyses of the outcome trajectory over time based on Generalized Estimating Equations (GEEs) result in biased estimates of regression coefficients. Inverse-intensity weighted GEEs (IIW-GEEs) are a popular approach to account for informative assessment times and yield unbiased estimates of outcome model coefficients when the assessment times and outcomes are conditionally independent given previously observed data. However, a consequence of irregular assessment times is that some patients may have no follow-up assessments at all, and it is common practice to omit these patients from analyses when studying the outcome trajectory over time.
methodsWe show mathematically that IIW-GEEs yield biased estimates of regression coefficients when patients with no follow-up assessments are excluded from analyses. We design a simulation study to evaluate how the bias varies with sample size, assessment frequency, follow-up time, and the informativeness of the assessment time process. Using the STAR*D trial of treatments for major depressive disorder, we examine the extent of bias in practice.
resultsOur simulation results showed the bias incurred by omitting patients with no follow-up visits increased as visit frequency decreased and as the duration of follow-up decreased. In the STAR*D trial, omitting patients with no follow-up visits led to over-estimation of the rate of improvement in depressive symptoms.
conclusionsStudies should be designed to ensure patients with no follow-up are included in the data. This can be achieved by a) creating inception cohorts; b) when taking sub-samples of existing cohorts, ensuring that patients without follow-up assessments are included; c) dropping exclusion criteria based on availability of follow-up visits.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.